Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million Series A to Advance Pipeline of Precision Therapeutics Based on Groundbreaking Integrated Disease Network Mapping Platform

Press/Media

Period	17 Nov 2022

Media coverage

Title	Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million Series A to Advance Pipeline of Precision Therapeutics Based on Groundbreaking Integrated Disease Network Mapping Platform
Media name/outlet	BioSpace
Country/Territory	United States
Date	17/11/22
URL	https://www.biospace.com/article/releases/rezo-founded-by-renowned-ucsf-scientists-launches-with-78-million-series-a-to-advance-pipeline-of-precision-therapeutics-based-on-groundbreaking-integrated-disease-network-mapping-platform/?s=89
Persons	Nevan Krogan